Adinil Pharma Private Limited - Company Profile

It is a business services private limited company based in Huzur, Madhya Pradesh, India, established in 2023.
2023 Huzur, Madhya Pradesh, India Active
Last Updated:
Access Report
About Adinil Pharma Private Limited

Adinil Pharma Private Limited, a active private limited company, was established on 26 December 2023 in Huzur, Madhya Pradesh, India. it holds CIN: U46497MP2023PTC069106. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jitendra Singh Raghuwanshi (Director), Sujay Raghuwanshi (Additional Director), Anil Khatri (Director). Past directors included Aditya Ramsharan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H No E 100, Minal Residency, Jk Road, Huzur, Madhya Pradesh, 462023.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497MP2023PTC069106

  • Registration Number

    069106

  • Incorporation Date

    26 December 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
Company report

Adinil Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Adinil Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Adinil Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jitendra Singh Raghuwanshi Director 26 Dec 2023 Current
Sujay Raghuwanshi Additional Director 02 Feb 2024 Current
Anil Khatri Director 26 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Feb 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Adinil Pharma.

Enhance accessibility to Adinil Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Adinil Pharma revenue growth over time
Adinil Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Adinil Pharma?

Unlock access to Adinil Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Adinil Pharma?

Unlock and access historical data on people associated with Adinil Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Adinil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adinil Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Adinil Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Adinil Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Adinil Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Director Appointment

    Sujay Raghuwanshi was appointed as a Additional Director was appointed as a Additional Director on 02 Feb 2024 & has been associated with this company since 2 years 8 days . was recorded as a recent event.

  • Director Appointment

    The activity Jitendra Singh Raghuwanshi was appointed as a Director was appointed as a Director on 26 Dec 2023 & has been associated with this company since 2 years 1 month . was completed.

  • Director Appointment

    Anil Khatri was appointed as a Director was appointed as a Director on 26 Dec 2023 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Adinil Pharma Private Limited was registered on 26 Dec 2023 with Roc Gwalior & aged 2 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Adinil Pharma Private Limited?

The CIN of Adinil Pharma Private Limited is U46497MP2023PTC069106.

Where is Adinil Pharma Private Limited headquartered?

Adinil Pharma Private Limited is headquartered at H No E 100, Minal Residency, Jk Road, Huzur, Madhya Pradesh, 462023.

When was Adinil Pharma Private Limited incorporated?

Adinil Pharma Private Limited was incorporated on 26 December 2023.

Who are the current directors of Adinil Pharma Private Limited?

The current directors of Adinil Pharma Private Limited are

Is Adinil Pharma Private Limited a listed company?

Adinil Pharma Private Limited is unlisted.

What is the capital structure of Adinil Pharma Private Limited?

The authorized capital of Adinil Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available